CN108450938A - A kind of fat reducing meal replacement powder and preparation method thereof - Google Patents
A kind of fat reducing meal replacement powder and preparation method thereof Download PDFInfo
- Publication number
- CN108450938A CN108450938A CN201710090939.5A CN201710090939A CN108450938A CN 108450938 A CN108450938 A CN 108450938A CN 201710090939 A CN201710090939 A CN 201710090939A CN 108450938 A CN108450938 A CN 108450938A
- Authority
- CN
- China
- Prior art keywords
- parts
- fat reducing
- weight
- meal replacement
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 28
- 235000012054 meals Nutrition 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims description 6
- 235000019197 fats Nutrition 0.000 claims abstract description 36
- 239000002131 composite material Substances 0.000 claims abstract description 27
- 239000011782 vitamin Substances 0.000 claims abstract description 26
- 229940088594 vitamin Drugs 0.000 claims abstract description 26
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 235000005911 diet Nutrition 0.000 claims abstract description 18
- 239000006041 probiotic Substances 0.000 claims abstract description 18
- 235000018291 probiotics Nutrition 0.000 claims abstract description 18
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 15
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 15
- 239000011707 mineral Substances 0.000 claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 14
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 13
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 13
- 230000000378 dietary effect Effects 0.000 claims abstract description 13
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 13
- 150000004667 medium chain fatty acids Chemical class 0.000 claims abstract description 12
- 230000000529 probiotic effect Effects 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 230000037213 diet Effects 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 23
- 235000010755 mineral Nutrition 0.000 claims description 14
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- 102000007544 Whey Proteins Human genes 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 3
- 239000005862 Whey Substances 0.000 claims description 3
- 235000013734 beta-carotene Nutrition 0.000 claims description 3
- 239000011648 beta-carotene Substances 0.000 claims description 3
- 235000010439 isomalt Nutrition 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 150000000992 L-arabinoses Chemical class 0.000 claims description 2
- 150000001579 beta-carotenes Chemical class 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical class [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- FEZWOUWWJOYMLT-DSRCUDDDSA-M cobalt;[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,1 Chemical compound [Co].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FEZWOUWWJOYMLT-DSRCUDDDSA-M 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- 150000003625 trehaloses Chemical class 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000019161 pantothenic acid Nutrition 0.000 claims 1
- 230000036186 satiety Effects 0.000 abstract description 15
- 235000019627 satiety Nutrition 0.000 abstract description 15
- 230000000968 intestinal effect Effects 0.000 abstract description 7
- 208000020442 loss of weight Diseases 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000001788 irregular Effects 0.000 abstract description 3
- 231100001261 hazardous Toxicity 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 102000004407 Lactalbumin Human genes 0.000 description 5
- 108090000942 Lactalbumin Proteins 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000000577 adipose tissue Anatomy 0.000 description 5
- 235000003642 hunger Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229940009289 bifidobacterium lactis Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- 208000012866 low blood pressure Diseases 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- NBGXQZRRLOGAJF-UHFFFAOYSA-N Maltulose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)(CO)OCC1O NBGXQZRRLOGAJF-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- JCQLYHFGKNRPGE-HFZVAGMNSA-N maltulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-HFZVAGMNSA-N 0.000 description 1
- 150000002711 medium chain fatty acid esters Chemical class 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of fat reducing meal replacement powders, which is characterized in that by weight ratio for：10 20 parts of potato extracts, 10 20 parts of conjugated linoleic acid, 10 20 parts of medium chain fatty acids, 10 20 parts of composite dietaries, 10 20 parts of composite mineral matters, 10 20 parts of multi-vitamins, 1 20 parts of protein powders, 10 20 parts of compound probiotics.Since potato extract is added in fat reducing meal replacement powder, be conducive to quickly increase the satiety of eater, and conjugated linoleic acid and medium chain fatty acid is added, fat metabolism can be promoted to balance, and other nutriments and functional mass are compounded by optimization, can be that life is busy, the irregular obese people of diet realizes the purpose of easily non-hazardous loss of weight, can also adjust intestinal flora balance additionally by compound probiotic is increased, improve intestinal environment, realize multi-pronged, science fat reducing.
Description
Technical field
The present invention relates to diet food field, more particularly to a kind of fat reducing meal replacement powder and preparation method thereof.
Background technology
Obesity is a kind of morbid state of body excess accumulation fat, is often as the energy contained by body dietary intake and is more than
Caused by the energy consumed, takes in excessive energy and stored in the form of fat, cause body fat to be assembled, cause body
Increase again, body fat increases.Obesity can cause the physiological and pathological of human body to change, and generate huge harm to health, be mainly shown as
Coronary heart disease, hypertension, diabetes and other diseases more easily occur for overweight people.
Although and there are many method of weight-reducing at present on the market, wherein it is most common to drink slim tea to carry out control body weight, are somebody's turn to do
Method harm is very big, including the following aspects：
1, it is easy to cause diarrhea
Diarrhea, which is many slim teas, can all generate, and many men and women that lose weight do not take diarrhea seriously, they think slim tea
It is exactly by diarrhoea, gut purge defecation works, but if long-term diarrhea, very big damage can be brought to our stomach
Wound, it is easy to lead to gastrointestinal disease, cause the disorders of digestion.
2, it be easy to cause malnutrition
The all different degrees of meeting of slim tea inhibits the appetite of people, allow everybody feel belly it is full be just not desired to feed, the time
As soon as length, the nutrition that needed by human body is wanted is unable to fully supply, to damage health.
3, it be easy to cause low blood pressure
Slim tea has diuresis ingredient, is used for a long time, has the drainage system for body of speaking sarcastically, and often a large amount of dehydrations, can cause
Human electrolyte's metabolic disorder, so as to cause the appearance of low blood pressure.
4, it is easy to change constitution fever and chills
Ingredient inside slim tea is all much cold and cool property, and as lotus leaf, folium sennae etc., these are all the medium-height grass of cool property
Medicine is eaten for a long time these things, be easy to cause cold body.
Therefore, there is an urgent need for a kind of more safely and effectively methods, and such as by controlling the intake of food, that is, using being capable of part
Instead of or all instead of the food of dinner, the metabolic demand of body can be met and the heat of intake is effectively controlled
System, to reach the glycogen and fat of consumption body storage, to achieve the purpose that loss of weight of losing weight.
And weight-losing meal-substituting foodstuff type on the market is dazzling at present, but more or less there are satiety is bad, satisfy
The abdomen time is short, and nutrition configures the problem of imbalance etc., and there is also poor tastes on, eat the problems such as inconvenient.
Invention content
The technical problem to be solved in the present invention is to provide a kind of fat reducing meal replacement powder, which can make one quickly to generate abdomen of satisfying
Sense, busy to live to promote fat metabolism to balance, the irregular obese people of diet realizes the purpose of loss of weight, simultaneously should
Meal replacement powder adjusts intestinal flora balance, improves intestinal environment, realizes multi-pronged, science fat reducing.
In order to solve the above-mentioned technical problem, the technical scheme is that a kind of fat reducing meal replacement powder, by weight ratio such as
Under：
10-20 parts of potato extracts, 10-20 parts of conjugated linoleic acid, 10-20 parts of medium chain fatty acids, 10-20 portions of compound meals
Eat fiber, 10-20 parts of composite mineral matters, 10-20 parts of multi-vitamins, 1-20 parts of protein powders, 10-20 parts of compound probiotics.
Preferably, the composition of composite dietary is by weight：1-10 portions of trehaloses, 1-10 parts of oligofructose, 1-10
Part isomalt, 1-10 parts of L-arabinoses.
Preferably, the composition of composite mineral matter is by weight：0-1 parts of magnesia, 0-1 parts of potassium chloride, 0-1 parts of pantothenic acid
Calcium, 0-1 parts of calcium carbonate, 0-1 parts of calcium lactates include at least two kinds in component therein.
Preferably, multi-vitamins composition is by weight：0-1 parts of beta carotenes, 0-1 parts of vitamin Cs, 0-1 parts of dimension lifes
Plain D, 0-1 part vitamin E, 0-1 parts of vitamin B1s, 0-1 parts of vitamin B2s, 0-1 parts of vitamin B6s, 0-1 parts of vitamin B12s,
In component in include at least two kinds.
Preferably, protein powder is PURE WHEY.
Preferably, the composition of compound probiotic is by weight：1-10 parts of lactobacillus acidophilus, 1-10 parts of lactobacillus plantarums,
1-10 parts of bifidobacterium longums, 1-10 parts of bifidobacterium lactis, 1-10 parts of Lactobacillus rhamnosus.
A kind of preparation method of fat reducing generation meal, steps are as follows：
Mixing：Potato extract, conjugated linoleic acid, medium chain fatty acid, composite dietary, grandidierite are weighed by weight
Substance, multi-vitamins, protein powder are added trough type mixing machine and mix 30 minutes, obtain mixture；
Sterilizing：Mixture in step 1 is used into ultraviolet disinfection；
Strain is added：Compound probiotic is added in mixture after sterilizing, is packed, sealing.
Be conducive to quickly increase edible since potato extract is added in fat reducing meal replacement powder using above-mentioned technical proposal
The satiety of person, and conjugated linoleic acid and medium chain fatty acid is added, fat metabolism can be promoted to balance, and compound it by optimizing
His nutriment and functional mass can be to live busy, and the irregular obese people of diet realizes light non-hazardous loss of weight
Purpose can also adjust intestinal flora balance additionally by compound probiotic is increased, improve intestinal environment, and realization is multi-pronged,
Science fat reducing.
Specific implementation mode
The specific implementation mode of the present invention is described further below.It should be noted that for these implementations
The explanation of mode is used to help understand the present invention, but does not constitute limitation of the invention.In addition, invention described below
Involved technical characteristic can be combined with each other as long as they do not conflict with each other in each embodiment.
Potato extract is that Slendesta active constituents are extracted in potato, can increase satiety, effectively reduces food
It is intended to, promotes metabolic especially fat metabolism, reduce neutral fat, free fatty acid content, block Amylase Hydrolysis, will form sediment
Powder is decomposed into monosaccharide, reduces fat and hoards, reduce the content of total cholesterol etc. in blood plasma, accelerates fat combustion, promotes basic generation
It thanks, inhibits lipase activity, reduce neutral fat content in blood, protect gastric mucosa, improve intestinal flora, improve machine
Body is metabolized, and is enhanced human immunity and resistance, and commercial product is used.
Conjugated linoleic acid is naturally occurring in organism, and the functional motor ability substance of great application value is drawn in the world
Great concern is played.Studies have shown that conjugated linoleic acid has anticancer, anti arteriosclerosis, reduces body fat, adjust blood glucose, improve
All more important physiologic functions such as immunity.As a kind of new nutrient, used extensively in American-European conjugated linoleic acid at present
In various fields such as healthy food, food additives, drug, cosmetics.
Medium chain fatty acid be usually implemented as operation after, infection and skin burn patient special food, it may also be used for those
Bad with fat absorption, the food of aids patient and cancer patient, diabetes patient can be used for treating hyperplasia of prostate, dissipate
Cholelith, reduction cholesterol, anti-curing hyperlipemia etc..In addition it may also help in weight-reducing, in practice it has proved that, eat medium chain fatty acid ester
MCT has obvious effects on the weight of human body, the reduction of stomach fat area, the reduction of waistline.
Protein more can effectively extend the time between two meal than carbohydrate, or more effectively reduce next meal card road
In take in and compared with edible casein beverage, edible lactalbumin drink can cause the stronger satiety of people and lower food
Object intake, and in numerous protein, lactalbumin can lead to lower food intake dose.
The composition of composite dietary in the present invention is by weight：1-10 parts of trehalose, 1-10 parts of oligofructose are different
1-10 parts of maltulose alcohol, 1-10 parts of L-arabinose, and the composition of composite dietary can carry out tune appropriate as needed
Match, and it is essentially identical for effect of the present invention for the dietary fiber of different composition, can be had an impact to the satiety of experimenter,
The effect of its satiety is similar, is only allocated with the ratio for according to parts by weight being 1 part in following embodiments, i.e., compound
The group of dietary fiber becomes：1 part of trehalose, 1 part of oligofructose, 1 part of isomalt, 1 part of L-arabinose, content most
In the case of low, the influence to satiety is also minimum, and increasing its influence to satiety with content increases.Composite mineral matter can root
According to needing to carry out allotment appropriate, on the sense of born of the same parents' abdomen without influence, i.e., what arbitrary selection was two or more or more arrange in pairs or groups, Xia Shushi
The composite mineral matter only formed with 0.5 part of calcium pantothenate and 0.5 part of potassium chloride in example is applied to illustrate；Similarly, multi-vitamins
With 0.5 part of beta carotene, 0.5 part of vitamin C, 0.5 part of vitamin D, 0.5 part of vitamin E, 0.5 part of vitamin B1,0.5 part of dimension
Raw element B2,0.5 part of vitamin B6, the mixed multi-vitamins formed of 0.5 part of vitamin B12 illustrate；Compound probiotic
With 5 parts of lactobacillus acidophilus, 5 parts of lactobacillus plantarums, 5 parts of bifidobacterium longums, 5 parts of bifidobacterium lactis, 5 parts of Lactobacillus rhamnosus mix
The compound probiotic formed is closed to illustrate.
Embodiment 1
In the present embodiment, the formula of fat reducing meal replacement powder is：15 parts of potato extracts, 15 parts of conjugated linoleic acid, in 15 parts
Chain fatty acid, 15 parts of composite dietaries, 15 parts of composite mineral matters, 15 parts of multi-vitamins, 15 parts of PURE WHEYs, 15 parts multiple
Close probiotics, prepare the step of be：
Mixing：Potato extract is weighed by above-mentioned parts by weight, conjugated linoleic acid, medium chain fatty acid, composite dietary,
Composite mineral matter, multi-vitamins, PURE WHEY are added trough type mixing machine and mix 30 minutes, obtain mixture；
Sterilizing：Mixture in step 1 is used into ultraviolet disinfection；
Strain is added：Compound probiotic is added in mixture after step 2 is sterilized, packs, sealing.
Embodiment 2
In the present embodiment, the formula of fat reducing meal replacement powder is：10 parts of potato extracts, 15 parts of conjugated linoleic acid, in 10 parts
Chain fatty acid, 20 parts of composite dietaries, 15 parts of composite mineral matters, 15 parts of multi-vitamins, 15 parts of PURE WHEYs, 15 parts multiple
Probiotics is closed, preparation method is same as Example 1.
Embodiment 3
In the present embodiment, fat reducing generation meal includes the ingredient of following parts by weight：20 parts of potato extracts, the sub- oil of 15 parts of conjugation
Acid, 20 parts of medium chain fatty acids, 20 parts of composite dietaries, 10 parts of composite mineral matters, 10 parts of multi-vitamins, 10 parts of lactalbumins
Powder, 10 parts of compound probiotics.
Embodiment 4
In the present embodiment, fat reducing generation meal includes the ingredient of following parts by weight：20 parts of potato extracts, the sub- oil of 10 parts of conjugation
Acid, 15 parts of medium chain fatty acids, 10 parts of composite dietaries, 20 parts of composite mineral matters, 20 parts of multi-vitamins, 20 parts of lactalbumins
Powder, 20 parts of compound probiotics.
Embodiment 5
In the present embodiment, fat reducing generation meal includes the ingredient of following parts by weight：20 parts of potato extracts, the sub- oil of 20 parts of conjugation
Acid, 15 parts of medium chain fatty acids, 10 parts of composite dietaries, 20 parts of composite mineral matters, 20 parts of multi-vitamins, 1 part of lactalbumin
Powder, 20 parts of compound probiotics.
120 volunteers of selection are randomly divided into four experimental groups and a control group, every group of 20 people, experimental group personnel according to
Recommendation method does not eat anything in 12 hours before edible test agent, and same time point in the morning, is corresponded to by group edible
Examples 1 to 5 given the test agent, control group use equivalent placebo (composite mineral matter, multi-vitamins, compound probiotic group
At), customization heat breakfast of the same race is eaten after half an hour, same time point progress satiety visual analogue scales survey after eat
One end of examination, the horizontal line of standardized 10cm on paper, horizontal line is 0, indicates no satiety；The other end is 10, indicates very full；
Middle section indicates different degrees of satiety.It allows experimenter according to the standardized mark on horizontal line is felt, indicates abdomen of satisfying
Degree, do per hour later satiety visual analogue scales test, record subject's satiety change with time, table 1 is
Test result statistical form：
| Time | First group | Second group | Third group | 4th group | 5th group | Control group |
| 0h | 6 | 6 | 6 | 6 | 6 | 6 |
| 1h | 5.5 | 5.2 | 5.3 | 5.1 | 5 | 4.8 |
| 2h | 5 | 4.6 | 4.8 | 4.9 | 4.6 | 3.8 |
| 3h | 4.5 | 4.0 | 4.2 | 4.2 | 4 | 3 |
Hunger indication test method is identical, wherein 0 one end indicates no hunger, and 10 indicate that hunger is very tight
Weight, 0-10 indicate the different degrees of of starvation, and final result is as follows：
| Time | First group | Second group | Third group | 4th group | 5th group | Control group |
| 0h | 0 | 0 | 0 | 0 | 0 | 0 |
| 1h | 2.5 | 2.8 | 3.0 | 2.9 | 2.5 | 3.5 |
| 2h | 3.8 | 3.9 | 4.1 | 4.1 | 4.0 | 5.1 |
| 3h | 5 | 5.2 | 5.5 | 5.4 | 5.1 | 6.7 |
Satiety is two opposite processes with hunger, can mutually be examined by above-mentioned test result, and final
Comparative result show that test result is consistent.
The fat volunteers of selection 120 are randomly divided into 5 experimental groups and a control group, every group of 20 people, experimental group according to
Recommendation method daily use Examples 1 to 5 given the test agent, control group use equivalent placebo, persistently use 2 months, record by
Examination person's weight and body fat rate variation, 2 test result statistical form of table：
| Test event | First group | Second group | Third group | 4th group | 5th group | Control group |
| Weight loss ratio | 10%-16% | 8%-16% | 12%-17% | 13%-15% | 9%-13% | 3%-5% |
| Body fat rate reduces | 4.5%-8.8% | 3.9%-9.0% | 4.5%-9.2% | 4.5%-9.5% | 5%-8.6% | - 1%-3% |
Embodiments of the present invention are explained in detail above, but the present invention is not limited to described embodiments.It is right
For those skilled in the art, in the case where not departing from the principle of the invention and spirit, these embodiments are carried out more
Kind change, modification, replacement and modification, still fall in protection scope of the present invention.
Claims (7)
1. a kind of fat reducing meal replacement powder, which is characterized in that as follows by weight ratio：
10-20 parts of potato extracts, 10-20 parts of conjugated linoleic acid, 10-20 parts of medium chain fatty acids, 10-20 portions of compound diets are fine
Dimension, 10-20 parts of composite mineral matters, 10-20 parts of multi-vitamins, 1-20 parts of protein powders, 10-20 parts of compound probiotics.
2. fat reducing meal replacement powder according to claim 1, which is characterized in that the composition of the composite dietary is by weight
For：1-10 portions of trehaloses, 1-10 parts of oligofructose, 1-10 parts of isomalts, 1-10 parts of L-arabinoses.
3. fat reducing meal replacement powder according to claim 1, which is characterized in that the composition of the composite mineral matter is by weight
For：0-1 parts of magnesia, 0-1 parts of potassium chloride, 0-1 parts of calcium pantothenates, 0-1 parts of calcium carbonate, 0-1 parts of calcium lactates, wherein all constituents
Two kinds are included at least in matter.
4. fat reducing meal replacement powder according to claim 1, which is characterized in that the multi-vitamins form is by weight：
0-1 parts of beta carotenes, 0-1 parts of vitamin Cs, 0-1 parts of vitamin Ds, 0-1 parts of vitamin Es, 0-1 parts of vitamin B1s, 0-1 parts of dimension lifes
Plain B2,0-1 part vitamin B6,0-1 parts of vitamin B12s, wherein including at least two kinds in all components.
5. fat reducing meal replacement powder according to claim 1, which is characterized in that the protein powder is PURE WHEY.
6. fat reducing meal replacement powder according to any one of claims 1-5, which is characterized in that the composition of the compound probiotic
It is by weight：1-10 parts of lactobacillus acidophilus, 1-10 parts of lactobacillus plantarums, 1-10 parts of bifidobacterium longums, 1-10 parts of newborn bifid bars
Bacterium, 1-10 parts of Lactobacillus rhamnosus.
7. a kind of preparation method of the fat reducing generation meal described in claim, which is characterized in that manufacturing step is as follows：
Mixing：Potato extract, conjugated linoleic acid, medium chain fatty acid, composite dietary, complex mineral are weighed by weight
Matter, multi-vitamins, protein powder are added trough type mixing machine and mix 30 minutes, obtain mixture；
Sterilizing：Mixture in step 1 is used into ultraviolet disinfection；
Strain is added：Compound probiotic is added in mixture after sterilizing, is packed, sealing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710090939.5A CN108450938A (en) | 2017-02-20 | 2017-02-20 | A kind of fat reducing meal replacement powder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710090939.5A CN108450938A (en) | 2017-02-20 | 2017-02-20 | A kind of fat reducing meal replacement powder and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108450938A true CN108450938A (en) | 2018-08-28 |
Family
ID=63222072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710090939.5A Pending CN108450938A (en) | 2017-02-20 | 2017-02-20 | A kind of fat reducing meal replacement powder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108450938A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109846035A (en) * | 2019-01-28 | 2019-06-07 | 广东达明益派生物科技有限公司 | A kind of compound probiotic composition with body weight control |
| CN111096416A (en) * | 2019-12-26 | 2020-05-05 | 宁波御坊堂生物科技有限公司 | Diet-depriving composition for weight-losing meal replacement and preparation method thereof |
| CN111493254A (en) * | 2020-04-10 | 2020-08-07 | 苏州绿叶日用品有限公司 | A solid beverage containing rhizoma Solani Tuber osi extract and its preparation method |
| CN111903914A (en) * | 2019-05-10 | 2020-11-10 | 杨杰 | Food with balanced nutrition, health and weight reduction effects |
| CN112401233A (en) * | 2020-12-02 | 2021-02-26 | 宣城柏维力生物工程有限公司 | Meal replacement powder with low carbohydrate dietary structure and preparation process thereof |
| CN113519733A (en) * | 2021-07-23 | 2021-10-22 | 广州食尚说食品投资有限公司 | Liquid ready-to-drink beverage and preparation method thereof |
| CN114376213A (en) * | 2021-11-30 | 2022-04-22 | 青岛澳海生物有限公司 | Fat-reducing meal replacement powder and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686532A (en) * | 2005-04-20 | 2005-10-26 | 湖南亚华乳业有限公司 | Conjugated linoleic acid contained nutrient for body weight reducing people |
| CN101849962A (en) * | 2010-04-15 | 2010-10-06 | 广东海洋大学 | Lipid-lowering and weight-losing complex nutrient preparation and preparation method thereof |
| CN102106498A (en) * | 2010-12-28 | 2011-06-29 | 北京康比特体育科技股份有限公司 | Weight losing meal-replacing powder |
| CN105395925A (en) * | 2015-11-27 | 2016-03-16 | 杭州海王生物工程有限公司 | Composition with hypotensive and anti-obesity effects based on blood fat reduction |
-
2017
- 2017-02-20 CN CN201710090939.5A patent/CN108450938A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686532A (en) * | 2005-04-20 | 2005-10-26 | 湖南亚华乳业有限公司 | Conjugated linoleic acid contained nutrient for body weight reducing people |
| CN101849962A (en) * | 2010-04-15 | 2010-10-06 | 广东海洋大学 | Lipid-lowering and weight-losing complex nutrient preparation and preparation method thereof |
| CN102106498A (en) * | 2010-12-28 | 2011-06-29 | 北京康比特体育科技股份有限公司 | Weight losing meal-replacing powder |
| CN105395925A (en) * | 2015-11-27 | 2016-03-16 | 杭州海王生物工程有限公司 | Composition with hypotensive and anti-obesity effects based on blood fat reduction |
Non-Patent Citations (2)
| Title |
|---|
| 微信 新营养: "马铃薯提取物-控制体重的好帮手", 《每日食品（HTTP://WWW.FOODAILY.COM/MARKET/SHOW.PHP?ITEMID=12836）》 * |
| 杨铁军: "《产业专利分析报告第16册》", 31 March 2013 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109846035A (en) * | 2019-01-28 | 2019-06-07 | 广东达明益派生物科技有限公司 | A kind of compound probiotic composition with body weight control |
| CN111903914A (en) * | 2019-05-10 | 2020-11-10 | 杨杰 | Food with balanced nutrition, health and weight reduction effects |
| CN111096416A (en) * | 2019-12-26 | 2020-05-05 | 宁波御坊堂生物科技有限公司 | Diet-depriving composition for weight-losing meal replacement and preparation method thereof |
| CN111493254A (en) * | 2020-04-10 | 2020-08-07 | 苏州绿叶日用品有限公司 | A solid beverage containing rhizoma Solani Tuber osi extract and its preparation method |
| CN112401233A (en) * | 2020-12-02 | 2021-02-26 | 宣城柏维力生物工程有限公司 | Meal replacement powder with low carbohydrate dietary structure and preparation process thereof |
| CN113519733A (en) * | 2021-07-23 | 2021-10-22 | 广州食尚说食品投资有限公司 | Liquid ready-to-drink beverage and preparation method thereof |
| CN113519733B (en) * | 2021-07-23 | 2023-11-07 | 广州食尚说食品投资有限公司 | Liquid instant drink and preparation method thereof |
| CN114376213A (en) * | 2021-11-30 | 2022-04-22 | 青岛澳海生物有限公司 | Fat-reducing meal replacement powder and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108450938A (en) | A kind of fat reducing meal replacement powder and preparation method thereof | |
| US6929793B2 (en) | Nutritional composition for treating an immune condition | |
| CN102657262B (en) | Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants | |
| CN108244252A (en) | Probiotics multielement protein powder and preparation method thereof | |
| US20220030909A1 (en) | Intact Pea Protein-Based Nutrient Composition | |
| CN115074274B (en) | Lactic acid bacteria-containing composition and use thereof | |
| WO2000012080A1 (en) | Diet composition and method of weight management | |
| KR20030031890A (en) | Carbohydrate system and a method for providing nutrition to a diabetic | |
| WO2002098242A1 (en) | Calorically dense liquid oral supplement | |
| CN109430407A (en) | Probiotic combinations preparation | |
| CN110226744A (en) | A kind of prostatitis tailored version clinical nutrition formula and preparation method thereof | |
| CN109846035A (en) | A kind of compound probiotic composition with body weight control | |
| CN108634151A (en) | A kind of probiotics egg nutrient powder and preparation method thereof | |
| CN108813627A (en) | A kind of special medicine purposes formula food composition and preparation method thereof with alimentary canal immunoloregulation function | |
| WO2009086614A1 (en) | Method and application of synbiotic food/feed composition for humans and animals | |
| Singh et al. | Food nutrition, science and technology | |
| CN107467193A (en) | Full nutrition special medicine purposes formula food of a kind of pulvis based on goat milk and preparation method thereof | |
| CN100350846C (en) | Method for preparing sour milk contg. micron ginseng and antler etc. with tonifying-kidney and eliminating fatigue functions | |
| CN109043555A (en) | A kind of Special food and preparation method thereof that hyperglycemic patients are edible | |
| CN100333652C (en) | Method for preparing milk powder contg. micron ginseng and antler etc. with tonifying-kidney and eliminating fatigue functions | |
| CN114145348A (en) | Food suitable for dysphagia patients and preparation method thereof | |
| CN104041553B (en) | The edible nutritive health biscuit of a kind of applicable the elderly | |
| CN111296827A (en) | Composition and application thereof | |
| CN105192698B (en) | A kind of health food containing leaf of Moringa powder and preparation method thereof | |
| KR20150018027A (en) | Grain fermentation enzyme powder with main ingredients Dite supplement food and its the manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20191210 Address after: No. 3101, 31 / F, building 4, Zhongyuan Mingdu, No. 30, North University Road, Erqi District, Zhengzhou City, Henan Province Applicant after: Henan Xiaoshan Health Technology Service Co., Ltd Address before: 510000 Guangdong Guangzhou Tianhe District Tianhe District Road, Lotte building 501 Applicant before: Guangzhou little hill Health Technology Co., Ltd. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180828 |
|
| RJ01 | Rejection of invention patent application after publication |